Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-alcoholic Steatohepatitis NASH”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03391401
What this trial is testing

Investigation of Microbiome-based Prognostical Biomarkers in Patients With Morbid Obesity and Bariatric Surgery

Who this might be right for
Obesity, MorbidBariatric Surgery CandidateNAFLD+1 more
St. Franziskus Hospital 204
Not applicableStudy completedNCT05357248
What this trial is testing

Nutritional Cognitive Behavioral Therapy Feasibility Study in NAFLD and NASH

Who this might be right for
Non-alcoholic SteatohepatitisNon-Alcoholic Fatty Liver DiseaseNon-alcoholic Fatty Liver
Better Therapeutics 22
Not applicableLooking for participantsNCT04634643
What this trial is testing

Pathogenesis of Pediatric Nonalcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
NAFLD
Yale University 260
Large-scale testing (Phase 3)Study completedNCT02908152
What this trial is testing

Curcumin Supplement in Nonalcoholic Fatty Liver Patients

Who this might be right for
Type 2 DiabetesNonalcoholic Fatty Liver
National Nutrition and Food Technology Institute 50
Post-approval studies (Phase 4)UnknownNCT01956825
What this trial is testing

The Effect Of Dual Treatment With L-Carnitine And Magnesium On Fatty Liver

Who this might be right for
Non Alcoholic Fatty Liver Disease
Meir Medical Center 60
Not applicableLooking for participantsNCT05816915
What this trial is testing

Lifestyle Modification in the Treatment of NAFLD.

Who this might be right for
NAFLD
General University Hospital, Prague 100
Not applicableActive Not RecruitingNCT05384652
What this trial is testing

Simultaneous Quantification of Liver Fat Content, Fatty Acid Composition, and Fibrosis Using Spin-lock MRI for Steatohepatitis Assessment

Who this might be right for
Non-alcoholic Fatty Liver Disease (NAFLD)Non-alcoholic Steatohepatitis (NASH)
Chinese University of Hong Kong 140
Not applicableNot Yet RecruitingNCT07430501
What this trial is testing

Using Digital Twin Technology and Clinical Decision Support Systems to Improve the Early Detection, Personalised Treatment, and Long-term Monitoring of Patients Across the Full Spectrum of Metabolic-associated Fatty Liver Disease (MAFLD).

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease
Hospital Universitari Vall d'Hebron Research Institute 7,720
Testing effectiveness (Phase 2)Study completedNCT03421431
What this trial is testing

Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis

Who this might be right for
Non-Alcoholic Steatohepatitis
Enanta Pharmaceuticals, Inc 134
Not applicableStudy completedNCT01674972
What this trial is testing

Glucose-induced Glucagon-like Peptide 1 (GLP-1) Secretion in NAFLD Patients Compared to Healthy Controls

Who this might be right for
Non Alcoholic Fatty Liver DiseaseNon Alcoholic Steatohepatitis
University Hospital, Basel, Switzerland 102
Post-approval studies (Phase 4)Study completedNCT03849729
What this trial is testing

Effectiveness and Tolerability of Phentermine in Patients Under Bariatric Surgery

Who this might be right for
ObesityMorbid ObesityBariatric Surgery+2 more
Hospital Juarez de Mexico 92
Not applicableUnknownNCT02133144
What this trial is testing

Effects of Overfeeding Followed by Weight Loss on Liver Fat Content and Adipose Tissue Inflammation

Who this might be right for
NAFLD
University of Helsinki 40
Not applicableStudy completedNCT04186260
What this trial is testing

A Gender and Culturally Specific Approach to Reduce NAFLD in Mexican-American Men

Who this might be right for
NAFLD
University of Arizona 15
Testing effectiveness (Phase 2)Study completedNCT00443079
What this trial is testing

Siliphos in Adults With Non-alcoholic Steatohepatitis (NASH)

Who this might be right for
Fatty Liver
Heather Patton 6
Not applicableUnknownNCT03386890
What this trial is testing

Clinical Application of Non-invasive Assessment for Staging Liver Steatosis and Liver Fibrosis

Who this might be right for
Nonalcoholic Fatty Liver DiseaseLiver SteatosisLiver Fibrosis
Beijing Friendship Hospital 400
Not applicableUnknownNCT06061640
What this trial is testing

The Potential Value and Impact of Diagnostic Biomarkers for MAFLD Using Machine Learning Methods

Who this might be right for
Metabolic Dysfunction-associated Fatty Liver Disease
The First Affiliated Hospital of Zhejiang Chinese Medical University 500
Early research (Phase 1)UnknownNCT04913090
What this trial is testing

A Phase I Clinical Trial of XZP-5610 Tablets in Healthy Subjects

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)
Xuanzhu Biopharmaceutical Co., Ltd. 112
Not applicableStudy completedNCT01787591
What this trial is testing

Dairy Fat as a Mediator of Vitamin E Adequacy in Individuals With Metabolic Syndrome

Who this might be right for
Non-alcoholic Fatty LiverMetabolic Syndrome
Ohio State University 21
Not applicableUnknownNCT03734510
What this trial is testing

The Effect of Supplementation of Flaxseed, Hesperidin, Flaxseed and Hesperidin Together in Non-alcoholic Fatty Liver Disease: A Randomized, Controlled Study

Who this might be right for
Non Alcoholic Steatohepatitis
National Nutrition and Food Technology Institute 100
Large-scale testing (Phase 3)Study completedNCT02132442
What this trial is testing

Hepatic Dysfunction, Vitamin D Status, and Glycemic Control in Diabetes

Who this might be right for
Type 2 DiabetesNonalcoholic Fatty Liver DiseaseVitamin D Deficiency
University of Massachusetts, Worcester 12
Next Page